Investigators in the Division of Pulmonary, Allergy and Critical Care Medicine have made a monumental discovery regarding idiopathic pulmonary Thannickalfibrosis, an often fatal lung disease with no cure and no effective treatments. In findings published March 1, 2013, in the Journal of Clinical Investigation, the research team has discovered a new pathway that contributes to fibrosis, or scarring in the lungs. More importantly, they may have also found a potential treatment to block that pathway.

To read more, go to:


Residents Recreate at Annual Camp Dismukes Retreat
Celebrating 12 Inter-Professional Scholar Teams at 7th Annual Geriatric Quality Symposium
DOM IT Takes 3rd Place at National REDCap Conference
Good News Update

Medical Grand Rounds Calendar

RSCH 2016 10 Header
EOM Header Traylor
Ask the Chair of the Department of Medicine